Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
Abstract Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
L Haataja, T Gurlo, CJ Huang, PC Butler - Endocrine Reviews, 2008 - europepmc.org
Abstract Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
L Haataja, T Gurlo, CJ Huang… - Endocrine …, 2008 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin secretion,
loss of beta-cell mass with increased beta-cell apoptosis and islet amyloid. The islet amyloid …
loss of beta-cell mass with increased beta-cell apoptosis and islet amyloid. The islet amyloid …
[PDF][PDF] Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
L Haataja, T Gurlo, CJ Huang, PC Butler - Endocrine Reviews - academia.edu
Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin secretion,
loss of ß-cell mass with increased ß-cell apoptosis and islet amyloid. The islet amyloid is …
loss of ß-cell mass with increased ß-cell apoptosis and islet amyloid. The islet amyloid is …
[HTML][HTML] Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
L Haataja, T Gurlo, CJ Huang, PC Butler - Endocrine Reviews, 2008 - ncbi.nlm.nih.gov
Abstract Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
[引用][C] Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
L HAATAJA, T GURLO, CJ HUANG… - Endocrine …, 2008 - pascal-francis.inist.fr
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search …
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
L Haataja, T Gurlo, CJ Huang, PC Butler - Endocrine Reviews, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Type 2 diabetes (T2DM) is characterized by
insulin resistance, defective insulin secretion, loss of β-cell mass with increased β-cell …
insulin resistance, defective insulin secretion, loss of β-cell mass with increased β-cell …
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
L Haataja, T Gurlo, CJ Huang, PC Butler - Endocrine Reviews, 2008 - europepmc.org
Abstract Type 2 diabetes (T2DM) is characterized by insulin resistance, defective insulin
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
secretion, loss of β-cell mass with increased β-cell apoptosis and islet amyloid. The islet …
[引用][C] Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
L HAATAJA - Endocr Rev., 2008 - cir.nii.ac.jp
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …